$BOTY
LINGERIE FIGHTING CHAMPIONSHIPS, INC.

2024 Q4 Form 10-Q Financial Statement

#000164033424001502 Filed on October 11, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2024 Q2 2023 Q2
Revenue $34.48K $31.11K
YoY Change 10.84% -3.61%
Cost Of Revenue $23.34K $15.96K
YoY Change 46.24% 6.68%
Gross Profit $11.14K $15.15K
YoY Change -26.47% -12.5%
Gross Profit Margin 32.31% 48.7%
Selling, General & Admin $12.74K $51.37K
YoY Change -75.2% -4.16%
% of Gross Profit 114.37% 339.05%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $111.3K $51.37K
YoY Change 116.75% 3.36%
Operating Profit -$100.2K -$36.22K
YoY Change 176.67% 11.85%
Interest Expense $95.11K $66.66K
YoY Change 42.69% -2.86%
% of Operating Profit
Other Income/Expense, Net $1.490M $609.6K
YoY Change 144.34% -37.33%
Pretax Income $1.389M $573.4K
YoY Change 142.3% -39.02%
Income Tax $0.00 $0.00
% Of Pretax Income 0.0% 0.0%
Net Earnings $1.389M $573.4K
YoY Change 142.3% -39.02%
Net Earnings / Revenue 4029.48% 1843.3%
Basic Earnings Per Share
Diluted Earnings Per Share $0.00 $0.00
COMMON SHARES
Basic Shares Outstanding 4.505B shares
Diluted Shares Outstanding 13.85B shares 10.37B shares

Balance Sheet

Concept 2024 Q4 2024 Q2 2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $10.45K $3.410K
YoY Change 206.45% -86.72%
Cash & Equivalents $10.45K $3.411K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $10.45K $3.411K
YoY Change 206.33% -89.72%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $1.00 -$1.00
YoY Change -200.0%
TOTAL ASSETS
Total Short-Term Assets $10.45K $3.411K
Total Long-Term Assets $1.00 -$1.00
Total Assets $10.45K $3.410K
YoY Change 206.45% -89.72%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $699.1K $644.7K
YoY Change 8.43% 28.9%
Accrued Expenses $790.6K $552.6K
YoY Change 43.08% 65.05%
Deferred Revenue
YoY Change
Short-Term Debt $1.100M $978.3K
YoY Change 12.45% 11.42%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $5.030M $4.407M
YoY Change 14.15% -13.38%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $5.030M $4.407M
Total Long-Term Liabilities $0.00 $0.00
Total Liabilities $5.030M $4.407M
YoY Change 14.15% -13.38%
SHAREHOLDERS EQUITY
Retained Earnings -$10.14M -$9.442M
YoY Change 7.42% -5.36%
Common Stock $3.955M $3.712M
YoY Change 6.55% 4.99%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$5.020M -$4.403M
YoY Change
Total Liabilities & Shareholders Equity $10.45K $3.411K
YoY Change 206.33% -89.72%

Cashflow Statement

Concept 2024 Q4 2024 Q2 2023 Q2
OPERATING ACTIVITIES
Net Income $1.389M $573.4K
YoY Change 142.3% -39.02%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$89.40K $3.500K
YoY Change -2654.29% -110.25%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change
Cash From Investing Activities $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 97.50K -900.0
YoY Change -10933.33% -102.0%
NET CHANGE
Cash From Operating Activities -89.40K 3.500K
Cash From Investing Activities 0.000
Cash From Financing Activities 97.50K -900.0
Net Change In Cash 8.100K 2.600K
YoY Change 211.54% -76.08%
FREE CASH FLOW
Cash From Operating Activities -$89.40K $3.500K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
3896930 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1206572 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-9302609 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-4199107 usd
us-gaap Revenues
Revenues
79508 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5295 usd
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
904056 usd
CY2024Q2 us-gaap Assets Current
AssetsCurrent
10449 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
5295 usd
CY2024Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
1450 usd
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
10495 usd
CY2024Q2 boty Related Party Transaction Amounts Of Transaction Accounts Payable
RelatedPartyTransactionAmountsOfTransactionAccountsPayable
697628 usd
CY2023Q4 boty Related Party Transaction Amounts Of Transaction Accounts Payable
RelatedPartyTransactionAmountsOfTransactionAccountsPayable
642128 usd
dei Entity Central Index Key
EntityCentralIndexKey
0001407704
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
51 shares
CY2024Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
51 shares
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
51 shares
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
10000000000 shares
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
3954844036 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
3896928536 shares
boty Share Based Compensation Arrangement By Share Based Payment Award Options Redeemed
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsRedeemed
0 shares
CY2023 boty Share Based Compensation Arrangement By Share Based Payment Award Options Redeemed
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsRedeemed
0 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
0 shares
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
0 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
0.0000
CY2023 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
0.0000
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-55498
dei Entity Registrant Name
EntityRegistrantName
LINGERIE FIGHTING CHAMPIONSHIPS, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
20-8009362
dei Entity Address Address Line1
EntityAddressAddressLine1
6955 North Durango Drive
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 1115-129
dei Entity Address City Or Town
EntityAddressCityOrTown
Las Vegas
dei Entity Address State Or Province
EntityAddressStateOrProvince
NV
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
89149
dei City Area Code
CityAreaCode
702
dei Local Phone Number
LocalPhoneNumber
505-0743
dei Entity Current Reporting Status
EntityCurrentReportingStatus
No
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
No
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
4504844036 shares
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
10449 usd
CY2024Q2 us-gaap Interest Payable Current
InterestPayableCurrent
790626 usd
CY2023Q4 us-gaap Interest Payable Current
InterestPayableCurrent
669015 usd
CY2024Q2 us-gaap Notes Payable Current
NotesPayableCurrent
340000 usd
CY2023Q4 us-gaap Notes Payable Current
NotesPayableCurrent
340000 usd
CY2024Q2 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
619530 usd
CY2023Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
619530 usd
CY2024Q2 us-gaap Debt Instrument Unamortized Discount Current
DebtInstrumentUnamortizedDiscountCurrent
108919 usd
CY2023Q4 us-gaap Debt Instrument Unamortized Discount Current
DebtInstrumentUnamortizedDiscountCurrent
64016 usd
CY2024Q2 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
140525 usd
CY2023Q4 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
84428 usd
CY2024Q2 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
2440532 usd
CY2023Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
1838806 usd
CY2024Q2 us-gaap Liabilities Current
LiabilitiesCurrent
5030291 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
4204402 usd
CY2024Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2024Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2024Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
51 shares
CY2024Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
10000000000 shares
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
3954844036 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
3896928536 shares
CY2024Q2 us-gaap Common Stock Value
CommonStockValue
3954846 usd
CY2024Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1168356 usd
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-10143044 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-5019842 usd
CY2024Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
10449 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
5295 usd
CY2024Q2 us-gaap Revenues
Revenues
34480 usd
CY2023Q2 us-gaap Revenues
Revenues
31108 usd
us-gaap Revenues
Revenues
56303 usd
CY2024Q2 us-gaap Cost Of Revenue
CostOfRevenue
23340 usd
CY2023Q2 us-gaap Cost Of Revenue
CostOfRevenue
15957 usd
us-gaap Cost Of Revenue
CostOfRevenue
57543 usd
us-gaap Cost Of Revenue
CostOfRevenue
40803 usd
CY2024Q2 us-gaap Gross Profit
GrossProfit
11140 usd
CY2023Q2 us-gaap Gross Profit
GrossProfit
15151 usd
us-gaap Gross Profit
GrossProfit
21965 usd
us-gaap Gross Profit
GrossProfit
15500 usd
CY2024Q2 us-gaap Salaries And Wages
SalariesAndWages
30000 usd
CY2023Q2 us-gaap Salaries And Wages
SalariesAndWages
30000 usd
us-gaap Salaries And Wages
SalariesAndWages
60000 usd
us-gaap Salaries And Wages
SalariesAndWages
60000 usd
CY2024Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
12741 usd
CY2023Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
8822 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
24514 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
26926 usd
CY2024Q2 us-gaap Professional Fees
ProfessionalFees
68605 usd
CY2023Q2 us-gaap Professional Fees
ProfessionalFees
12548 usd
us-gaap Professional Fees
ProfessionalFees
76252 usd
us-gaap Professional Fees
ProfessionalFees
25146 usd
CY2024Q2 us-gaap Operating Expenses
OperatingExpenses
111346 usd
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
51370 usd
us-gaap Operating Expenses
OperatingExpenses
160766 usd
us-gaap Operating Expenses
OperatingExpenses
112072 usd
CY2024Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-100206 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-36219 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-138801 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-96572 usd
CY2024Q2 us-gaap Interest Expense
InterestExpense
95114 usd
CY2023Q2 us-gaap Interest Expense
InterestExpense
66656 usd
us-gaap Interest Expense
InterestExpense
177708 usd
us-gaap Interest Expense
InterestExpense
138239 usd
CY2024Q2 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
1584685 usd
CY2023Q2 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
970712 usd
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-523926 usd
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
1030522 usd
CY2024Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1489571 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-701634 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
892283 usd
CY2024Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1389365 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
867837 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-840435 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
795711 usd
CY2024Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2024Q2 us-gaap Profit Loss
ProfitLoss
1389365 usd
CY2023Q2 us-gaap Profit Loss
ProfitLoss
867837 usd
us-gaap Profit Loss
ProfitLoss
-840435 usd
us-gaap Profit Loss
ProfitLoss
795711 usd
CY2024Q2 boty Earnings Per Common Shares Basic And Diluted
EarningsPerCommonSharesBasicAndDiluted
0.00
CY2023Q2 boty Earnings Per Common Shares Basic And Diluted
EarningsPerCommonSharesBasicAndDiluted
0.00
boty Earnings Per Common Shares Basic And Diluted
EarningsPerCommonSharesBasicAndDiluted
-0.00
boty Earnings Per Common Shares Basic And Diluted
EarningsPerCommonSharesBasicAndDiluted
0.00
CY2024Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
CY2024Q2 boty Basic And Diluted Weighted Average Shares Of Common Stock Outstanding
BasicAndDilutedWeightedAverageSharesOfCommonStockOutstanding
3711714036 shares
CY2023Q2 boty Basic And Diluted Weighted Average Shares Of Common Stock Outstanding
BasicAndDilutedWeightedAverageSharesOfCommonStockOutstanding
3711714036 shares
boty Basic And Diluted Weighted Average Shares Of Common Stock Outstanding
BasicAndDilutedWeightedAverageSharesOfCommonStockOutstanding
3972664190 shares
boty Basic And Diluted Weighted Average Shares Of Common Stock Outstanding
BasicAndDilutedWeightedAverageSharesOfCommonStockOutstanding
3711714036 shares
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
13853459194 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10370856034 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14114409348 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10370856034 shares
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-4199107 usd
CY2024Q1 boty Stock Issued During Period Value Stock Warrants Exercised
StockIssuedDuringPeriodValueStockWarrantsExercised
19700 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-2229800 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-6409207 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
1389365 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-5019842 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-4572242 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-72126 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-4644368 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
867837 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-3776531 usd
us-gaap Profit Loss
ProfitLoss
-840435 usd
us-gaap Profit Loss
ProfitLoss
795711 usd
us-gaap Gain Loss On Sale Of Derivatives
GainLossOnSaleOfDerivatives
-523926 usd
us-gaap Gain Loss On Sale Of Derivatives
GainLossOnSaleOfDerivatives
1030522 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
56097 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
28558 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-9045 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
14374 usd
us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
55500 usd
us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
50600 usd
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
121611 usd
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
109681 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-92346 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-31598 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
97500 usd
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
0 usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
0 usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
25000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
97500 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
25000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
5154 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-6598 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5295 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
10009 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
10449 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3411 usd
us-gaap Interest Paid Net
InterestPaidNet
0 usd
us-gaap Interest Paid Net
InterestPaidNet
0 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
boty Common Stock Issued For Exercise Of Warrants
CommonStockIssuedForExerciseOfWarrants
19700 usd
boty Common Stock Issued For Exercise Of Warrants
CommonStockIssuedForExerciseOfWarrants
0 usd
us-gaap Nature Of Operations
NatureOfOperations
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>NOTE 1 – ORGANIZATION AND NATURE OF BUSINESS</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Lingerie Fighting Championships, Inc. (the “Company”) is a Nevada corporation incorporated on November 29, 2006 under the name Sparking Events, Inc. The Company’s corporate name was changed to Xodtec Group USA, Inc. in June 2009, Xodtec LED, Inc. in May 2010, Cala Energy Corp. in September 2013 and Lingerie Fighting Championships, Inc. on April 1, 2015.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company focuses on developing, producing, promoting, and distributing entertainment through live entertainment events, digital home videos, broadcast television networks, video on demand, and digital media channels in the United States. It offers wrestling and mixed martial arts fights featuring women under the LFC brand name.</p>
us-gaap Use Of Estimates
UseOfEstimates
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date the financial statements and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimates. The Company continually evaluates its estimates and judgments. The Company bases its estimates and judgments on historical experience and other factors that it believes to be reasonable under the circumstances. Materially different results can occur as circumstances change and additional information becomes known, even for estimates and judgments that are not deemed critical.</p>
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
5594708812 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.0002
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
6533630698 shares
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.0002
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
57915500 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
3.50 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0447 pure
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
1296925 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
1093440 shares
CY2024Q2 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
619530 usd
CY2023Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
619530 usd
CY2023Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
1838806 usd
CY2024Q2 us-gaap Derivative Liabilities
DerivativeLiabilities
2440532 usd

Files In Submission

Name View Source Status
0001640334-24-001502-index-headers.html Edgar Link pending
0001640334-24-001502-index.html Edgar Link pending
0001640334-24-001502.txt Edgar Link pending
0001640334-24-001502-xbrl.zip Edgar Link pending
boty-20240630.xsd Edgar Link pending
boty_10q.htm Edgar Link pending
boty_ex311.htm Edgar Link pending
boty_ex321.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
boty-20240630_cal.xml Edgar Link unprocessable
boty-20240630_def.xml Edgar Link unprocessable
boty-20240630_lab.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
boty-20240630_pre.xml Edgar Link unprocessable
boty_10q_htm.xml Edgar Link completed
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending